Literature DB >> 7588997

Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.

R B Simmons1, G R Newton, V M Doctor.   

Abstract

[125I]-Labeled thrombin was incubated with human plasma and its interactions with the two plasma protease inhibitors antithrombin III (AT-III) or heparin cofactor II (HC-II) were investigated in the presence of oat spelts xylan sulfate (OSXS), sodium pentosan polysulfate (SP-54), and the results were compared with heparin and dermatan sulfate. Addition of OSXS or SP-54 enhanced the complexation of thrombin with HC-II or with both AT-III and HC-II depending upon the concentration and the duration of the interactions of the sulfated compounds with plasma. During the 30 s interaction, OSXS and SP-54 enhanced both AT-III-thrombin and HC-II-thrombin interaction while heparin was more selective and enhanced only the AT-III-thrombin interaction. However after a 2 min interaction, heparin showed an increase in the HC-II-thrombin interaction at higher concentrations. The complexations of AT-III-thrombin and HC-II-thrombin were reversed in the presence of 200 micrograms/ml of SP-54 during a 30 s interaction or in presence of 100 micrograms/ml of OSXS during a 2 min interaction. The Western blotting method of detecting thrombin showed that during the 10 s interaction, heparin enhanced the thrombin-AT-III complex formation while OSXS enhanced the thrombin-HC-II complex formation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588997     DOI: 10.1007/BF03192291

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  17 in total

1.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

2.  Mechanism of potentiation of antithrombin III [AT-III] inhibition by sulfated xylans.

Authors:  A Campbell; M E Nesheim; V M Doctor
Journal:  Thromb Res       Date:  1987-08-01       Impact factor: 3.944

3.  The purification and mechanism of action of human antithrombin-heparin cofactor.

Authors:  R D Rosenberg; P S Damus
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

4.  The binding of thrombin to the surface of human platelets.

Authors:  D M Tollefsen; J R Feagler; P W Majerus
Journal:  J Biol Chem       Date:  1974-04-25       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Some properties of antithrombin-III and its concentration in human plasma.

Authors:  G Murano; L Williams; M Miller-Andersson; D L Aronson; C King
Journal:  Thromb Res       Date:  1980 Apr 1-15       Impact factor: 3.944

7.  The heparin and pentosan polysulfate binding sites of human antithrombin overlap but are not identical.

Authors:  X J Sun; J Y Chang
Journal:  Eur J Biochem       Date:  1989-10-20

8.  Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure.

Authors:  D M Tollefsen; C A Pestka
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

9.  Detection of a new heparin-dependent inhibitor of thrombin in human plasma.

Authors:  D M Tollefsen; M K Blank
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

10.  Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.

Authors:  D M Tollefsen; D W Majerus; M K Blank
Journal:  J Biol Chem       Date:  1982-03-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.